CareLit Fachartikel

Treatment of chronic Hepatitis C Genotype 1 (G1) infection with Boceprevir (BOC) in German Real-Life: Impact of Hemoglobin (Hb) decline on virologic response

G Teuber, P Buggisch, H Löhr, H Steffens, M Kraus, C John, P Geyer, B Weber, T Witthoeft, A Herrmann, M Hoesl, U Naumann, T Dahhan, D Hartmann, B Dreher, M Bilzer · Zeitschrift für Gastroenterologie · 2014 · Heft 08

Dokument
1052815
CareLit-ID
Jahr
2014
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Zeitschrift für Gastroenterologie
Autor:innen
G Teuber, P Buggisch, H Löhr, H Steffens, M Kraus, C John, P Geyer, B Weber, T Witthoeft, A Herrmann, M Hoesl, U Naumann, T Dahhan, D Hartmann, B Dreher, M Bilzer
Ausgabe
Heft 08 / 2014
Seiten
–
Erschienen: 2014-08-11 00:00:00
ISSN
0044-2771
DOI
10.1055/s-0034-1386295

Zusammenfassung

Background: Data regarding the severity and impact of hemoglobin (Hb) decline caused by triple therapy with boceprevir (BOC) in real-life are still scarce and were evaluated in the present interim analysis of the German NOVUS observational study. Methods: From April 2012 until November 2013, 469 patients with G1 infection were recruited in the ongoing NOVUS study by 97 practices and hospitals in Germany. Patients were treated with pegylated interferons (PegIFN) and ribavirin (RBV) together with BOC for 24 to 44 weeks after a 4 week lead-in period with PegIFN/RBV. The present interim analysis was restricted to 15…

Schlagworte

Zeitschrift für Gastroenterologie